Mode
Text Size
Log in / Sign up

MMSE-CDR-SB residual deviation from AD pattern linked to non-AD pathologies in autopsy and clinical cohortsA simple score spots brain changes that are not typical Alzheimer's disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the MMSE-CDR-SB residual as an exploratory triage signal for non-AD pathologies in Alzheimer's disease evaluations.

This cohort study analyzed an autopsy cohort (n=1,981) and a clinical diagnosis cohort (n=3,184) from NACC data. The intervention or exposure was the MMSE-CDR-SB residual, which summarizes deviation from an AD-typical cognitive-functional pattern, using an AD-oriented reference equation as the comparator. The primary outcome was deviation from an AD-typical cognitive-functional pattern.

Lower residual values were associated with lower odds of amyloid and AD-type tau pathology. Positive residual values showed a directional but nonspecific association with non-AD co-pathologies, including TDP-43 and vascular burden. Positive residual values were enriched in PSP and FTLD-other. AD cases clustered near the reference pattern.

No safety or tolerability data were reported. Key limitations include that the residual appears to summarize deviation from an AD-typical pattern rather than indicate one specific pathology, and positive residual values showed a directional but nonspecific association with selected non-AD co-pathologies.

Practice relevance is that this may serve as an exploratory triage-level signal of a less AD-typical presentation. Associations were examined using multivariable logistic regression, and the certainty note is that this is an exploratory indicator.

Many people with memory loss have brain changes that do not fit the standard picture of Alzheimer's disease. This study looked at nearly 2,000 people who passed away and had their brains examined. Researchers also reviewed data from over 3,000 living patients. They used a specific score to measure how much a person's brain function deviated from the typical pattern seen in Alzheimer's.

The results showed that lower scores matched the usual Alzheimer's brain changes. However, higher scores pointed toward other conditions. These included TDP-43 and vascular burden, which are different types of brain damage. The study also found that these higher scores were linked to Progressive Supranuclear Palsy and other forms of dementia.

This finding matters because it offers a way to sort out complex cases. It acts as an early signal that a patient might have a less typical presentation. The researchers noted that this score is exploratory and does not pinpoint one specific disease on its own. It helps guide further testing when the standard Alzheimer's picture does not fit.

What this means for you:
A new score helps identify brain changes that differ from typical Alzheimer's disease patterns.

Study Details

Study typeCohort
Sample sizen = 1,981
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
INTRODUCTION: We tested whether the MMSE-CDR-SB residual, defined as observed minus expected CDR-SB from an AD-oriented reference equation, reflects deviation from an AD-typical cognitive-functional pattern. METHODS: Using NACC data, we analyzed an autopsy cohort (n=1,981) and a separate clinical diagnosis cohort (n=3,184). Associations were examined using multivariable logistic regression adjusted for MMSE band, age, sex, and education. RESULTS: Lower residual values were associated with lower odds of amyloid and AD-type tau pathology. Positive residual values showed a directional but nonspecific association with selected non-AD co-pathologies, including TDP-43 and vascular burden. In the clinical cohort, positive residual values were enriched in PSP and FTLD-other, whereas AD cases clustered near the reference pattern. DISCUSSION: The residual appears to summarize deviation from an AD-typical cognitive-functional pattern rather than indicate one specific pathology, and may serve as an exploratory triage-level signal of a less AD-typical presentation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.